RIBONUCLEASE SUPERFAMILY--STRUCTURE-FUNCTION STUDIES
RIBONUCLEASE SUPERFAMILY--STRUCTURE-FUNCTION STUDIES
批准号:
3309159
负责人:
STEVEN C. ALMO
金额:
$20.14万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1996-07-31
关键词:
X ray crystallography active sites angiogenesis factor antineoplastics chemical kinetics crystallization cyclic nucleoside monophosphate cytosine nucleotides deoxyribonucleotides dinucleotide enzyme activity enzyme mechanism enzyme structure enzyme substrate enzyme substrate analog enzyme substrate complex hybrid enzyme laboratory rabbit ligands mutant neurotoxins pancreatic ribonuclease protein structure function site directed mutagenesis tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project is concerned with obtaining detailed structure-function
correlations for members of the ribonuclease superfamily. This family
of proteins includes digestive enzymes such bovine pancreatic
ribonuclease (RNase A), toxins, such as human eosinophil derived
neurotoxin, growth factors such as human angiogenin, and P-30, a protein
with significant toxicity against human tumor cell lines. The sequence
homology and ribonucleolytic activity of all these proteins, suggests
that they share a common catalytic mechanism and tertiary structure. The
vast amount of structural and biochemical information available for RNase
A provides a unique opportunity to examine the basis for the biological
activities displayed by members of the ribonuclease superfamily. RNase
A will be systematically mutated towards the primary sequence of these
homologs, and the hybrid proteins will be examined by X-ray
crystallography, kinetics and the appropriate bioassays.
In every case, the biological activities have been linked to the
ribonucleolytic activity. It is therefore crucial to understand the
detailed enzymatic mechanism(s) used by the various homologs. In
addition to unraveling the connection between enzymatic activity and
biological function, the production of hybrid proteins will allow for the
study of phenomena which are of fundamental importance to enzymology.
Specifically, members of the ribonuclease superfamily utilize the binding
energy of extended substrates to enhance catalytic efficiency by up to
four orders of magnitude. Furthermore, the rate of catalysis in the
superfamily is highly sensitive to the identity of amino acids which are
not directly involved in either the chemical transformation or substrate
binding: kcat/Km spans six orders of magnitude across the superfamily.
How enzymatic activity is effected by interactions distant from the site
of chemistry is one of the outstanding questions in enzymology, and is
of general importance.
The production of hybrid ribonucleases will allow for an examination of
important biological activities such as neurotoxicity, growth factor
activity and tumor cytotoxicity. In addition, these same studies will
address the fundamental question of 'long range distant effects' in
catalysis. Defining the structural and chemical determinants responsible
for these biological activities will be instrumental in understanding
their underlying mechanism and in providing a basis for therapeutic
development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10834306
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10548600
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10807389
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10634689
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Cancer Therapuetics
-
批准号:10429332
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2021
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9752177
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10596609
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9908044
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10375382
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells
-
批准号:10335165
-
项目类别:
-
资助金额:$71.58万
-
财政年份:2018
-
负责人:STEVEN C. ALMO
-
依托单位:
Function and Mechanism of Viperin, a radical SAM antiviral protein
-
批准号:9375148
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2017
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9322344
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9489077
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9749981
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:10003466
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9106970
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9926079
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
An integrated X-ray data collection system
-
批准号:9145388
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:9868371
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:8887877
-
项目类别:
-
资助金额:$64.8万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
海外基金